论文部分内容阅读
随着制药行业研发成本的暴增,药物临床研究外包需求持续上涨并不断变化,更加专业、个性化而非通用型模式。药企也会根据不同需求选择领域不同的合同研究组织(CRO)公司,比如数据管理、业务扩展等特定服务。FierceCRO列出了5大CRO公司与制药企业的战略合作案例。安斯泰来制药和INC Research:4月,安斯泰来和INC Research宣布扩展合作关系,包括建立一个为期三年的功能性服务商(FSP)联盟,INC Research将向这家日本制药巨头提供包括临床监察、试验管理、文件管理、试验启动、可行性研究和临床数据管理在内的各种服务。3
With the surge in R & D costs in the pharmaceutical industry, the demand for outsourced drug clinical research continues to grow and change, becoming more professional, personal, and non-generic. Pharmaceutical companies will also select different CRO companies based on different needs, such as data management, business expansion and other specific services. FierceCRO lists five major CRO companies and pharmaceutical companies strategic cooperation case. Astellas Pharma & INC Research: In April, Astellas and INC Research announced an expanded partnership that will include the establishment of a three-year FSP consortium to be provided by INC Research to the Japanese pharmaceutical giant Including clinical monitoring, trial management, document management, pilot start-up, feasibility studies and clinical data management, including a variety of services. 3